Skip to main content

Table 1 Baseline characteristics of patients

From: Effect and safety of intraoperative intraperitoneal chemotherapy on patients suffering from colorectal cancer

Characteristic

Patients, no.

Surgery without IOC

(N=220)

Surgery plus IOC

(N= 171)

P value

Age, mean (SD), y

60.4(9.7)

60.6(8.7)

.85

Sex

 Male

137

114

.37

 Female

83

57

 

Hypertension

 Yes

57

49

.55

 No

163

122

 

Diabetic mellitus

 Yes

38

30

.94

 No

182

141

 

 CEA, mean (SD), ng/mL

8.41(14.90)

9.07(15.41)

.67

Tumor location

 Right colon

64

39

.37

 Left colon

48

40

 

 Rectal

108

92

 

 Tumor size, mean (SD), cm

4.8(1.6)

4.6(1.7)

.42

Pathologic T category

 T1

4

3

.84

 T2

8

9

 

 T3

195

147

 

 T4

13

12

 

Pathologic N category

 N0

96

80

.76

 N1

93

66

 

 N2

31

25

 

TNM stage

 II

96

80

.54

 III

124

91

 

Differentiation

 Well

6

4

.44

 Moderate

204

154

 

 Poor

10

13

 

Pathological type

 Tubular adenocarcinoma

209

159

.12

 Mucinous adenocarcinoma

7

3

 

 Mixed adenocarcinoma

4

9

 

Vascular invasion

 Yes

86

65

.83

 No

134

106

 

Postoperative chemotherapy

 Yes

122

92

.75

 No

98

79

 
  1. Abbreviation: IOC Intraoperative intraperitoneal chemotherapy